Published in
Elsevier, Clinical Microbiology and Infection, 4(21), p. 386.e1-386.e9
DOI: 10.1016/j.cmi.2014.10.022
Links
Tools
Use of efavirenz or atazanavir/ritonavir is associated with better clinical outcomes of HAART compared to other protease inhibitors: routine evidence from the Italian MASTER Cohort
Journal article published in 2015 by
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 